Diametric Capital »

Arrowhead Pharmaceuticals shares owned by Diametric Capital

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $694k 8.5k 81.51

More positions owned by Diametric Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Precigen (PGEN)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Fulgent Genetics (FLGT)
Ishares Tr Msci Eafe Etf (EFA)
A2z Cust2mate Solutions Corp (AZ)
Uniqure Nv SHS (QURE)
Liquidia Corporation Com New (LQDA)
Almonty Inds Com New (ALM)
Golar Lng SHS (GLNG)
Calumet (CLMT)
Abivax Sa Sponsored Ads (ABVX)
Digital Realty Trust (DLR)
Telephone & Data Sys Com New (TDS)
MGM Resorts International. (MGM)

View all positions for Diametric Capital

Top funds holding Arrowhead Pharmaceuticals

BlackRock
venBio Select Advisor
FMR
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Norges Bank Investment Management
Invesco
Geode Capital Management
Fred Alger Management
Baker Bros. Advisors
Susquehanna International
Siren
Vestal Point Capital
Henderson Group

View all funds holding Arrowhead Pharmaceuticals